Patients prescribed liraglutide saw similar rates with 62% of patients with class 3 obesity and 45% of patients with a healthy BMI maintaining or losing additional weight after one year
What to Expect During Your First Weeks on GLP-1 Treatment Understanding what to anticipate during the initial phase of GLP-1 therapy can help you manage expectations and identify any concerning symptoms that require medical attention
International Journal of Molecular Sciences , 25(2), 1314
Potential Risks of Combining These Two Medicines Combining these agents carries unpredictable risks to glycaemic control, as tesamorelin-induced insulin resistance may oppose retatrutide's metabolic effects, alongside class-level risks of pancreatitis, gallbladder disease, and fluid retention
What can you tell us about this research
The glutathione tirzepatide stack addresses oxidative stress and metabolic resilience, not gastrointestinal tolerance